Abstract:Abstract Objectives: To examine the interaction between general practitioners and pharmaceutical company representatives. Design: Qualitative study of 13 consecutive meetings between general practitioner and pharmaceutical representatives. A dramaturgical model was used to inform analysis of the transcribed verbal interactions. Setting: Practice in south west England. Participants: 13 pharmaceutical company representatives and one general practitioner. Results: The encounters were acted out in six scenes. Scene 1 was initiated by the pharmaceutical representative, who acknowledged the relative status of the two players. Scene 2 provided the opportunity for the representative to check the general practitioner's knowledge about the product. Scene 3 was used to propose clinical and cost benefits associated with the product. During scene 4, the general practitioner took centre stage and challenged aspects of this information. Scene 5 involved a recovery strategy as the representative fought to regain equilibrium. In the final scene, the representative tried to ensure future contacts. Conclusion: Encounters between general practitioners and pharmaceutical representatives follow a consistent format that is implicitly understood by each player. It is naive to suppose that pharmaceutical representatives are passive resources for drug information. General practitioners might benefit from someone who can provide unbiased information about prescribing in a manner that is supportive and sympathetic to the demands of practice. What is already known on this topic Pharmaceutical representatives influence physicians' prescribing in ways that are often unacknowledged by the physicians themselves Meetings with pharmaceutical representatives are associated with increased prescribing costs and less rational prescribing What this study adds Meetings between pharmaceutical representatives and general practitioners follow a consistent format that is implicitly understood by each player General practitioners may cooperate because representatives make them feel valued

Solution-processed Organic Crystals Written Directly with a Rollerball Pen for Field-Effect Transistors

Directly writing 2D organic semiconducting crystals for high-performance field-effect transistors

A Transfer Method for High‐Mobility, Bias‐Stable, and Flexible Organic Field‐Effect Transistors

Dramaturgical study of meetings between general practitioners and representatives of pharmaceutical companies; Commentary: dramaturgical model gives valuable insight.

Solution-processed organic crystals for field-effect transistor arrays with smooth semiconductor/dielectric interface on paper substrates

Large-scale Fabrication of Field-Effect Transistors Based on Solution-Grown Organic Single Crystals

Solution-processed crystalline organic integrated circuits

Controlling the crystal formation in solution-process for organic field-effect transistors with high-performance

Solution-processed Organic Single-Crystalline Semiconductors with a Fence-Like Shape Via Ultrasound Concussion

A Dry-Transfer Method for Molecular Monolayer Crystals Toward Flexible High-Performance Organic Field-Effect Transistors

Driving Organic Field-Effect Transistors: Enhancing Crystallization and Electrical Performance with Blends and Inkjet Printing

Controlled 2D growth of organic semiconductor crystals by suppressing “coffee-ring” effect

Solution-processed, Self-organized Organic Single Crystal Arrays with Controlled Crystal Orientation

Large plate-like organic crystals from direct spin-coating for solution-processed field-effect transistor arrays with high uniformity

Patterning Solution-Processed Organic Single-Crystal Transistors with High Device Performance

Solution-processed top-contact electrodes strategy for organic crystalline field-effect transistor arrays

Solution‐Processed 2D Molecular Crystals: Fabrication Techniques, Transistor Applications, and Physics

Patterning of organic semiconductor crystal arrays via microchannel-assisted inkjet printing for organic field-effect transistors

Low-voltage, High-performance Organic Field-Effect Transistors Based on 2D Crystalline Molecular Semiconductors

Solution-Processed, Large-Area, Two-Dimensional Crystals of Organic Semiconductors for Field-Effect Transistors and Phototransistors

Two-dimensional quasi-freestanding molecular crystals for high-performance organic field-effect transistors